Practical realization of therapeutics that reverse or halt the progression of major neurodegenerative diseases.
open
United States, North America
WS03053
A persistent gap exists in realizing practical, scalable solutions for therapeutics that reverse or halt the progression of major neurodegenerative diseases. Scientific understanding, engineering readiness and institutional capacity remain insufficient to translate promising concepts into durable impact under real-world constraints of cost, skills and governance.